Estimated read time: 2-3 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] HEA MTC
[SU] NPT WOM
TO HEALTH, MEDICAL, AND NATIONAL EDITORS:
Susan Poorman Blackie Ovarian Cancer Foundation makes inaugural gift
of $125,000 to support The University of Texas MD Anderson Cancer
Center's ovarian cancer research
HOUSTON, March 27, 2014 /PRNewswire-USNewswire/ -- The Susan Poorman
Blackie Ovarian Cancer Foundation awarded its first research gift of
$125,000 to The University of Texas MD Anderson Cancer Center. Funds
will support MD Anderson Cancer Center's Ovarian Moon Shots program,
evaluating genetic markers to identify the most effective therapeutic
approaches for women with ovarian cancer. A portion of the gift will
also be used to help fund innovative research on early detection of
ovarian cancer.
"We are thrilled to be partnering with MD Anderson on this critically
important research," said Buck Dodson, Interim Executive Director for
the foundation. "Our mission is to fund innovative, promising cancer
research that will change the standard of care for ovarian cancer
patients - from detection to treatment to quality of life and
survival. This is perfectly aligned with the goals of MD Anderson's
Moon Shots program."
According to Anil Sood, M.D., Professor of Gynecologic Oncology &
Reproductive Medicine at MD Anderson, "This gift from the Susan
Poorman Blackie Ovarian Cancer Foundation will provide us with
incredible opportunities to aggressively move forward the work on new
approaches for ovarian cancer treatment through MD Anderson's Moon
Shots Program."
Each year, approximately 20,000 women in the United States are
diagnosed with ovarian cancer. There currently is not an accurate
screening test for ovarian cancer; many times there are no symptoms
until the disease has progressed to an advanced stage.
The Susan Poorman Blackie Ovarian Cancer Foundation was created in
2013 from the desire to detect ovarian cancer early and treat it
successfully. The organization's mission is to empower women with
knowledge of ovarian cancer and promote innovative, promising research
for early detection and treatment.
The University of Texas MD Anderson Cancer Center in Houston ranks as
one of the world's most respected centers focused on cancer patient
care, research, education and prevention. MD Anderson is one of only
41 comprehensive cancer centers designated by the National Cancer
Institute (NCI). For ten of the past 12 years, including 2013, MD
Anderson has ranked No. 1 in cancer care in "Best Hospitals," a survey
published annually in U.S. News & World Report. MD Anderson receives a
cancer center support grant from the NCI of the National Institutes of
Health (P30 CA016672).
SOURCE Susan Poorman Blackie Ovarian Cancer Foundation
-0- 03/27/2014
/CONTACT: Buck Dodson, 1-800-428-4682, bdodson@spbovariancancerfoundation.org
/Web Site: http://www.spbovariancancerfoundation.org
CO: Susan Poorman Blackie Ovarian Cancer Foundation
ST: Texas
IN: HEA MTC
SU: NPT WOM
PRN
-- DC92582 --
0000 03/27/2014 20:11:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
